Very high CRP levels are associated with advanced, poorly responding metastatic cancers (55).CRP exists in two main forms: pentameric CRP (pCRP), the anti-inflammatory circulating form, and monomeric CRP (mCRP), which emerges during inflammation and is pro-inflammatory. Here, CRP is linked to metastatic malignant neoplasm.